Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / CALL
-
Number of holders
-
0
-
Price
-
$406.89
Significant Holders of VERTEX PHARMACEUTICALS INC - CALL as of Q4 2023
9 filings reported holding 92532F900 - VERTEX PHARMACEUTICALS INC - CALL as of Q4 2023.
VERTEX PHARMACEUTICALS INC - CALL has 0 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of shares
.
Largest 10 shareholders include GROUP ONE TRADING, L.P. (148,800 shares), SIMPLEX TRADING, LLC (94,000 shares), Twin Tree Management, LP (93,600 shares), JANE STREET GROUP, LLC (82,100 shares), SG Americas Securities, LLC (54,000 shares), JPMORGAN CHASE & CO (46,000 shares), IMC-Chicago, LLC (44,800 shares), Allianz Asset Management GmbH (11,900 shares), Maven Securities LTD (6,500 shares), and OSAIC HOLDINGS, INC. (1 shares).
This table shows the top 0 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.